Cytoplasmic tRNA 2-thiolation protein 1 (Ctu1) is a conserved enzyme critical for post-transcriptional tRNA modification. It facilitates the 2-thiolation of wobble uridine (U34) in cytosolic tRNAs, specifically tRNA(Lys), tRNA(Glu), and tRNA(Gln), forming the mcm⁵s²U modification. This modification enhances translational fidelity by stabilizing codon-anticodon interactions and preventing frameshifting or misreading . While Ctu1 is well-characterized in humans, yeast, and zebrafish, no direct studies or recombinant protein data for Rat Ctu1 are available in the provided sources.
Recombinant Ctu1 proteins from other species share structural and functional homology, suggesting potential parallels for rat homologs:
Note: Recombinant rat Ctu1 is not explicitly documented in the provided literature.
Binding and Catalysis: Ctu1 binds tRNA directly and catalyzes adenylation, a prerequisite for sulfur transfer at U34 .
Complex Formation: In yeast and C. elegans, Ctu1 partners with Ctu2 to form the cytosolic thiouridylase complex, essential for sulfur incorporation .
Genome Stability: Loss of Ctu1 in S. pombe causes ploidy defects and thermosensitive growth, linked to translational errors .
Developmental Roles: Zebrafish ctu1 mutants exhibit angiogenesis defects and erythroid differentiation impairment, highlighting its role in vertebrate development .
Yeast and Nematodes:
Zebrafish:
tRNA Binding: UV cross-linking assays confirm Ctu1’s direct interaction with tRNA(Lys) but not tRNA(Met) .
Enzymatic Activity: LC/MS-MS analyses detect mcm⁵s²U loss in ctu1 knockout strains, confirming its thiolation role .
Despite extensive characterization in other species, no studies or recombinant rat Ctu1 proteins are reported in the provided sources. Key unresolved questions include:
Structural differences between rat and human/mouse Ctu1.
Tissue-specific expression patterns in rat models.
Functional validation in rat-derived cell lines or in vivo systems.
Expression Systems: Rat Ctu1 could be synthesized using established platforms like ALiCE® (cell-free tobacco lysate), which successfully produces human Ctu1 with >70% purity .
Functional Studies: Assays analogous to yeast tRNA-binding experiments could clarify rat-specific enzymatic kinetics.
Disease Models: Investigating rat Ctu1’s role in conditions linked to tRNA dysregulation (e.g., neurodegeneration) remains unexplored.
Ctu1 functions as the catalytic component of the cytosolic thiouridylase complex responsible for 2-thiolation of mcm(5)S(2)U at tRNA wobble positions. Specifically, it catalyzes the addition of a thiol group at the C2 position (s2) of the 34th wobble uridine in the anticodon loop of select tRNAs. This modification is crucial for both restricting wobble in the corresponding split codon box and ensuring efficient codon-anticodon interaction during translation .
Ctu1 directly binds to target tRNAs and catalyzes their adenylation, which serves as an intermediate step required for 2-thiolation. While the complete mechanism remains under investigation, current evidence suggests Ctu1 plays a direct role in transferring sulfur from thiocarboxylated URM1 onto the uridine of tRNAs at the wobble position .
The Ctu1-Ctu2 complex specifically modifies three cytosolic tRNAs:
| tRNA | Anticodon | Modification |
|---|---|---|
| tRNAGln | UUG | mcm5s2U34 |
| tRNAGlu | UUC | mcm5s2U34 |
| tRNALys | UUU | mcm5s2U34 |
These tRNAs receive dual modifications: the 2-thiolation (s2) at the C2 position by Ctu1 and a methoxycarbonylmethyl group (mcm5) at the C5 position by other enzymes including Elongator and ALKBH8 . The combination of these modifications is critical for proper tRNA function during translation.
The cytosolic thiouridylase complex consists of two distinct subunits with complementary functions:
CTU1: Serves as the catalytic subunit responsible for the enzymatic 2-thiolation reaction at the 34th wobble uridine of the anticodon loop .
CTU2: Functions as a scaffold protein that facilitates the proper positioning and activity of Ctu1 .
This functional division reflects an evolutionary specialization that optimizes the efficiency and specificity of the thiolation process. The interaction between these two proteins creates a stable complex that can recognize and modify specific tRNAs with high fidelity.
Deficiency of Ctu1 leads to significant phenotypic consequences across multiple model organisms:
In fission yeast:
Thermosensitive decrease in viability
Marked ploidy abnormalities
Genomic instability
Translation defects potentially including both misreading and frameshifting
In vertebrates (zebrafish model):
Impaired angiogenesis
Developmental abnormalities
Cell cycle arrest
Defects in nerve development and erythrocyte differentiation
Attenuation of pro-angiogenic signaling pathways (e.g., angpt-tek and dll4-notch)
These findings demonstrate that the loss of proper tRNA thiolation has broad consequences for cellular function and organismal development, highlighting Ctu1's essential role.
Experimental evidence shows that Ctu1 directly binds to its target tRNAs. UV cross-linking studies using 32P-labeled T7-transcribed tRNA LYS UUU have demonstrated specific binding between Ctu1 and this tRNA substrate . The binding appears to be selective, as not all tRNAs interact with Ctu1 with equal affinity.
The protein likely recognizes specific structural features of the tRNA, particularly around the anticodon loop where the modification occurs. After binding, Ctu1 catalyzes the adenylation of tRNAs as an intermediate step required for the subsequent 2-thiolation reaction . This adenylation may involve the formation of a tRNA-AMP intermediate that activates the uridine for subsequent sulfur transfer.
Several complementary approaches can be employed to study Ctu1-tRNA interactions:
UV Cross-linking: Incubate purified Ctu1 (or Ctu1-TAP) with 32P-labeled tRNAs, perform UV cross-linking, purify the protein-RNA complexes (e.g., using IgG beads for TAP-tagged proteins), and analyze by PAGE and autoradiography .
Electrophoretic Mobility Shift Assays (EMSA): Titrate increasing concentrations of purified Ctu1 with labeled tRNA to determine binding constants and specificity.
Surface Plasmon Resonance (SPR): Immobilize either the protein or tRNA on a sensor chip and measure real-time binding kinetics.
RNA Immunoprecipitation (RIP): Use antibodies against tagged Ctu1 to precipitate bound tRNAs from cellular extracts, followed by RT-PCR or RNA sequencing to identify bound species.
Structural Biology: Approaches such as X-ray crystallography or cryo-EM of Ctu1-tRNA complexes can provide atomic-level details of the interaction.
When performing these experiments, it's crucial to include negative controls (non-thiolated tRNAs) and positive controls (known Ctu1 substrates like tRNALys UUU).
Distinguishing direct from indirect effects requires a multi-faceted approach:
Temporal Analysis: Use inducible knockdown/knockout systems to establish the sequence of events following Ctu1 depletion. Early events are more likely to be direct consequences.
Rescue Experiments: Complement Ctu1 deficiency with:
Single-cell RNA Sequencing: As employed in zebrafish studies, this can reveal transcriptional changes at high resolution and help establish causal relationships through pseudotime analysis and RNA velocity .
Direct Assessment of tRNA Modification: Quantify tRNA thiolation status alongside phenotypic development using APM gel electrophoresis or mass spectrometry to correlate specific molecular changes with phenotypic outcomes.
Pathway-specific Interventions: Target downstream pathways (e.g., VEGF signaling for angiogenesis defects) to determine if specific phenotypes can be rescued independently of tRNA thiolation.
Several complementary techniques can quantify tRNA thiolation with varying levels of sensitivity and specificity:
APM Gel Electrophoresis: N-acryloylamino phenyl mercuric chloride (APM) gel electrophoresis specifically retards the migration of thiolated tRNAs, allowing separation of thiolated from non-thiolated species . Northern blotting with specific probes can then identify and quantify particular tRNA species.
LC/MS-MS Analysis: Liquid chromatography coupled with tandem mass spectrometry can identify and quantify modified nucleosides after tRNA hydrolysis . This provides precise chemical identification of the thiolated nucleosides.
HPLC Analysis: High-performance liquid chromatography can separate modified nucleosides for quantification.
Next-generation Sequencing Approaches: Specialized RNA-seq methods that can detect modified bases provide genome-wide views of tRNA modification status.
A comparative quantification table for these methods might look like:
| Method | Sensitivity | Specificity | Throughput | Sample Requirement |
|---|---|---|---|---|
| APM Gel + Northern | Medium | High | Low | 5-10 μg total RNA |
| LC/MS-MS | Very High | Very High | Medium | 1-2 μg purified tRNA |
| HPLC | High | Medium | Medium | 2-5 μg purified tRNA |
| Modified RNA-seq | Medium | Medium | High | 1-5 μg total RNA |
Eukaryotic cells maintain distinct tRNA thiolation processes in different compartments:
Cytosolic Thiolation: Mediated by the Ctu1-Ctu2 complex for cytosolic tRNAs (tRNAGln, tRNAGlu, tRNALys) .
Mitochondrial Thiolation: Requires different factors, including Mtu1 (the mitochondrial homolog of bacterial MnmA) which functions as a tRNA-specific 2-thiouridylase .
Despite this compartmentalization, cross-talk exists between these systems. In yeast and T. brucei, the mitochondrial cysteine desulfurase Nfs1 is required for both mitochondrial and cytosolic tRNA thiolation . Similarly, components of mitochondrial Fe/S cluster assembly (ISC) and cytosolic Fe/S cluster assembly (CIA) machineries participate in tRNA modification in their respective compartments.
Interestingly, in organisms like T. brucei that import all tRNAs into mitochondria from the cytoplasm, some cytosolic thiolated tRNAs (tRNAGln and tRNAGlu) undergo de-thiolation following import by an unknown mechanism . This suggests sophisticated regulation of tRNA modification status between compartments.
Reconstituting tRNA thiolation in vitro remains challenging, as indicated by reports that "tRNA thiolation still cannot be efficiently reconstituted in vitro in any of these systems, suggesting the involvement of additional components" . Researchers attempting in vitro reconstitution should consider:
Protein Purification Strategy:
Tag selection minimizing interference with activity
Maintaining native protein folding and complexes
Co-purification with Ctu2 to maintain the functional complex
Substrate Preparation:
In vitro transcribed vs. cellular tRNAs (the latter may contain other modifications)
Proper tRNA folding conditions
Validation of tRNA structure
Reaction Components:
Detection Methods:
APM gel electrophoresis
LC/MS-MS analysis of reaction products
Labeled sulfur incorporation assays
A systematic approach testing different combinations of these factors would be advisable to successfully reconstitute the activity.
Ctu1 mutations impact translation in several ways:
Codon Recognition: Loss of tRNA thiolation impairs recognition of cognate codons, particularly AAA (Lys), GAA (Glu), and CAA (Gln) .
Translational Fidelity: Studies in fission yeast suggest that defects in Ctu1 lead to both misreading and frameshifting during translation .
Proteome Alterations: Inefficient translation of specific codons can lead to:
Decreased production of proteins enriched in affected amino acids
Increased translation errors
Protein misfolding and aggregation
Activation of proteostasis stress responses
Genome Instability: Remarkably, translation defects due to unmodified tRNAs result in severe genome instability, with marked ploidy abnormalities observed in fission yeast .
The precise mechanism linking translation defects to genome instability remains under investigation, but may involve impacts on the synthesis of DNA replication and repair factors, chromosome segregation proteins, or cell cycle regulators.
Multiple complementary approaches can identify Ctu1 interaction partners:
Affinity Purification-Mass Spectrometry (AP-MS):
TAP-tagging of Ctu1 followed by tandem affinity purification
Analysis of co-purifying proteins by mass spectrometry
Comparison with control purifications to identify specific interactors
Proximity Labeling:
BioID or TurboID fusion with Ctu1
Identification of proximal proteins by streptavidin purification and MS
Particularly useful for transient interactions
Yeast Two-Hybrid Screening:
Use Ctu1 as bait to screen cDNA libraries
Verification of interactions by co-immunoprecipitation
Genetic Interaction Screens:
Synthetic genetic array (SGA) analysis
CRISPR screens in Ctu1-depleted backgrounds
Identification of genes showing synthetic lethality or suppression
Computational Prediction:
Co-expression analysis across datasets
Phylogenetic profiling
Structural modeling of potential interaction surfaces
These approaches have different strengths for identifying stable complex components, transient regulatory factors, or functional relationships.
Ctu1 is highly conserved across eukaryotic species, from yeast to humans, suggesting fundamental importance in cellular function . Comparative analysis reveals:
Functional Conservation: The role of Ctu1 in tRNA thiolation appears to be conserved across species, with similar target tRNAs identified in organisms from yeast to humans .
Structural Features: Though specific domain information is limited in the search results, the high degree of sequence conservation suggests preservation of key catalytic and structural elements.
Phenotypic Consequences: Deficiency of Ctu1 leads to growth defects in yeast and developmental abnormalities in vertebrates, highlighting its fundamental importance .
Pathway Integration: The integration of Ctu1 with sulfur mobilization pathways appears conserved, though with some species-specific variations. In all examined systems, Ctu1 functions within a larger network of proteins involved in tRNA modification.
This evolutionary conservation provides a strong rationale for using model organisms to understand Ctu1 function and suggests that insights gained from these studies will likely be relevant to understanding human diseases associated with tRNA modification defects.